1. Home
  2. KNSA vs HE Comparison

KNSA vs HE Comparison

Compare KNSA & HE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • KNSA
  • HE
  • Stock Information
  • Founded
  • KNSA 2015
  • HE 1891
  • Country
  • KNSA United Kingdom
  • HE United States
  • Employees
  • KNSA N/A
  • HE N/A
  • Industry
  • KNSA Biotechnology: Pharmaceutical Preparations
  • HE Electric Utilities: Central
  • Sector
  • KNSA Health Care
  • HE Utilities
  • Exchange
  • KNSA Nasdaq
  • HE Nasdaq
  • Market Cap
  • KNSA 1.9B
  • HE 2.1B
  • IPO Year
  • KNSA 2018
  • HE N/A
  • Fundamental
  • Price
  • KNSA $35.71
  • HE $12.31
  • Analyst Decision
  • KNSA Strong Buy
  • HE Hold
  • Analyst Count
  • KNSA 6
  • HE 4
  • Target Price
  • KNSA $40.83
  • HE $10.94
  • AVG Volume (30 Days)
  • KNSA 439.9K
  • HE 2.3M
  • Earning Date
  • KNSA 10-28-2025
  • HE 08-07-2025
  • Dividend Yield
  • KNSA N/A
  • HE N/A
  • EPS Growth
  • KNSA N/A
  • HE N/A
  • EPS
  • KNSA 0.07
  • HE N/A
  • Revenue
  • KNSA $529,332,000.00
  • HE $3,122,881,000.00
  • Revenue This Year
  • KNSA $37.21
  • HE $12.58
  • Revenue Next Year
  • KNSA $11.99
  • HE $2.10
  • P/E Ratio
  • KNSA $539.78
  • HE N/A
  • Revenue Growth
  • KNSA 56.18
  • HE 2.36
  • 52 Week Low
  • KNSA $17.82
  • HE $8.14
  • 52 Week High
  • KNSA $35.82
  • HE $13.41
  • Technical
  • Relative Strength Index (RSI)
  • KNSA 72.49
  • HE 60.50
  • Support Level
  • KNSA $33.25
  • HE $12.08
  • Resistance Level
  • KNSA $34.16
  • HE $13.41
  • Average True Range (ATR)
  • KNSA 0.83
  • HE 0.33
  • MACD
  • KNSA 0.07
  • HE 0.01
  • Stochastic Oscillator
  • KNSA 95.59
  • HE 46.88

About KNSA Kiniksa Pharmaceuticals Ltd.

Kiniksa Pharmaceuticals International PLC is a clinical-stage biopharmaceutical company focused on discovering, acquiring, developing, and commercializing therapeutic medicines for patients suffering from debilitating diseases. The company's clinical-stage product candidates include Rilonacept, abiprubart, and mavrilimumab.

About HE Hawaiian Electric Industries Inc.

Hawaiian Electric Industries is the parent company of three Hawaii-based regulated utilities and owns a 10% minority interest in Hawaii's American Savings Bank. The utilities provide electricity on the five islands of Oahu, Hawaii, Maui, Molokai, and Lanai.

Share on Social Networks: